Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 12:10:966826.
doi: 10.3389/fpubh.2022.966826. eCollection 2022.

Effect of inactivated COVID-19 vaccination on intrauterine insemination cycle success: A retrospective cohort study

Zijin Xu  1 , Yixuan Wu  1 , Yanshan Lin  1 , Mingzhu Cao  1 , Zhu Liang  1 , Lei Li  1   2 , Jiali Lin  1 , Qian Chen  1 , Jianqiao Liu  1   2 , Haiying Liu  1   2
Affiliations

Effect of inactivated COVID-19 vaccination on intrauterine insemination cycle success: A retrospective cohort study

Zijin Xu et al. Front Public Health. .

Abstract

Background: Vaccine hesitancy was found in couples seeking artificial reproductive technology (ART) services. As the main vaccine used in China, investigations into the influence of inactivated coronavirus disease 2019 (COVID-19) vaccines on human fertility is needed.

Methods: This retrospective cohort study included data on COVID-19 vaccination, clinical characteristics, and reproductive outcome of 1,000 intrauterine insemination (IUI) cycles in 653 couples from March 2021 to March 2022 in a single university hospital-based center for reproductive medicine. The IUI cycles were divided into two categories based on sperm source, including 725 cycles in 492 women undergoing artificial insemination with their husband's sperm (AIH) and 275 cycles in 161 women undergoing artificial insemination with donor sperm (AID). Women were then divided into two groups. The vaccine exposed group included women vaccinated prior to insemination and the unexposed group included women who were not vaccinated or vaccinated after insemination. Reproductive outcomes including ongoing pregnancy rate, clinical pregnancy rate, and miscarriage rate were assessed.

Results: Inactivated COVID-19 vaccinated women prior to intrauterine insemination in AIH cycles have comparable ongoing pregnancy rate (11.1 vs. 10.3%, P = 0.73), clinical pregnancy rate (12.5 vs. 11.3%, P = 0.60) as compared with unvaccinated counterparts. Similarly, there were no significant differences in ongoing pregnancy rate (20.9 vs. 28.1%, P = 0.17), clinical pregnancy rate (21.7 vs. 28.8%, P = 0.19) between vaccine exposed and unexposed groups in AID cycles. Multivariable logistic regression analyses showed that inactivated COVID-19 vaccination status cannot independently influence the reproductive outcomes of AIH and AID cycles. Subgroup analysis of vaccine exposed cycles showed that doses of vaccination and Interval between the last dose of vaccination and insemination have no influence on the reproductive outcomes of AIH cycles.

Conclusions: No negative effects were found on female fertility in IUI cycles following exposure to the inactivated COVID-19 vaccine. These findings indirectly reflect the safety of inactivated COVID-19 vaccine toward reproductive health and help to mitigate vaccine hesitancy among people planning to conceive.

Keywords: COVID-19; IUI; SARS-CoV-2; inactivated vaccine; infertility.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Study flowchart.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Pavel S, Yetiskin H, Uygut MA, Aslan AF, Aydin G, Inan Ö, et al. . Development of an Inactivated Vaccine against SARS CoV-2. Vaccines. (2021) 9:1266. 10.3390/vaccines9111266 - DOI - PMC - PubMed
    1. World Health Organization . COVID-19 Weekly Epidemiological Update. (2022). Available online at: https://www.who.int/publications/m/item/weekly-epidemiological-update-on... (accessed March 15, 2022).
    1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. . Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. (2020) 395:565–74. 10.1016/S0140-6736(20)30251-8 - DOI - PMC - PubMed
    1. Nagy A, Alhatlani B. An overview of current COVID-19 vaccine platforms. Comput Struct Biotechnol J. (2021) 19:2508–17. 10.1016/j.csbj.2021.04.061 - DOI - PMC - PubMed
    1. World Health Organization . COVID-19 Vaccine Tracker and Landscape. (2022). Available online at: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand... (accessed March 15, 2022).

Publication types

Substances